馬來亞銀行將傑俐醫療集團有限公司（3H5）的評級從買入下調至持有。

TipRanks02/13 00:15 · 評級/大行評級

Health Care Roundup: Market Talk

WSJ02/12 17:20

Global Equities Roundup: Market Talk

WSJ02/12 14:04

Thomson Medical Likely Expanding Scope of Services -- Market Talk

WSJ02/12 13:34

Thomson Medical Group Target Price Raised to S$0.062 From S$0.047 by Maybank Research >A50.SG

道瓊斯02/12 13:08 · 評級/大行評級

傑俐在2026財年上半年因成本下降和穩定的表現將虧損收窄至$910萬。

每股虧損爲負0.039美分；EBITDA爲$3,890萬。傑俐集團報告稱，截至2025年12月31日的六個月（上半年）稅後淨虧損爲$910萬，較$12.6收窄了27.6%。

Singapore Business Review02/12 11:26